• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ATRC

ATRC

AtriCure, Inc.

NASDAQHealthcareMedical - Instruments & SuppliesUS

USD26.20

+0.34 (+1.31%)

Rating:C+

Company Profile

CEO

Michael H. Carrel

IPO Date

2005-08-05

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Exchange

NASDAQ

Country

US

Market Metrics

Open

$26.25

Prev. Close

$25.86

Day Low

$25.51

Day High

$26.63

52W Low

$25.36

52W High

$43.18

Market Cap

$1.33B

Volume

0.58M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

30.2%

Avg Negative

4.4%

Avg Neutral

65.5%

News Feed

AtriCure's (ATRC) CEO Mike Carrel on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/7/2021·↓ negative

AtriCure (ATRC) Reports Q2 Loss, Tops Revenue Estimates

Zacks Investment Research·8/4/2021·↑ positive

AtriCure to Participate at the Canaccord 41st Annual Growth Conference

Business Wire·7/30/2021·↑ positive

AtriCure (ATRC) Soars 8.8%: Is Further Upside Left in the Stock?

Zacks Investment Research·4/30/2021·↑ positive

AtriCure, Inc.'s (ATRC) CEO Mike Carrel on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·4/27/2021·↓ negative

AtriCure: Q1 Earnings Insights

Benzinga·4/27/2021·↑ positive

Preview: AtriCure's Earnings

Benzinga·4/26/2021·↓ negative

AtriCure, Inc. (ATRC) CEO Mike Carrel on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·2/23/2021·↓ negative

AtriCure to Announce Fourth Quarter and Full Year 2020 Financial Results

Business Wire·2/2/2021·↑ positive

AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2020

Business Wire·1/11/2021·↑ positive